跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
LACTULOSE SOLUTION USP
Authorized
STANDARD
LACTULOSE SOLUTION USP
Bajaj Medical, LLC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2a3a154e5070892f
Company
Bajaj Medical, LLC
Type
Standard
Approval Details
Approval Id
2a3a154e5070892f
Drug Approval Canada Name
LACTULOSE SOLUTION USP
Product Name
LACTULOSE SOLUTION USP
Status
Cancelled (Unreturned Annual)
Status Date
2025-01-29
Original Market Date
2001-02-19
Din
02242814
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Oral
Schedule
OTC
Ahfs
40:10.00
Atc Original
A06AD11 LACTULOSE
Atc Name
a 06 ad 11
Aig Number
0113020001
Company Name
Bajaj Medical, LLC
Company Address
415 W Pershing Rd, Chicago, Illinois, United States, 60609
Company Detail Path
/organization/bajaj-medical-llc
Company Information
Pharmaceutical Company Name
Bajaj Medical, LLC
Country Name
United States
Province Name
Illinois
City Name
chicago,illinois,country_us
Address
415 W Pershing Rd Ste 1
Active Ingredients
LACTULOSE
667 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2a3a154e5070892f
Type
Standard
Back to Health Canada Approvals
LACTULOSE SOLUTION USP - Health Canada Drug Approval Details